Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Should Rethink Its Definition Of A High-Risk Device, Say Patient Advocates

This article was originally published in The Gray Sheet

Executive Summary

Patient and consumer groups urged FDA to rethink its current stance on what constitutes a high-risk device at a meeting on the 510(k) program last week.
Advertisement

Related Content

FDA Panel: Transvaginal Mesh For Prolapse Should Be Class III
Institute Of Medicine On 510(k) Review Program: Dump It
Institute Of Medicine On 510(k) Review Program: Dump It

Topics

Advertisement
UsernamePublicRestriction

Register

MT030543

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel